@ARTICLE{Bilska-Wilkosz_Anna_α-Lipoic_2024,
 author={Bilska-Wilkosz, Anna and Głowacka, Kinga and Kocemba-Pilarczyk, Kinga A. and Marcykiewicz, Bernadeta and Gorny, Magdalena and Iciek, Małgorzata},
 volume={vol. 64},
 number={No 1},
 journal={Folia Medica Cracoviensia},
 pages={39-52},
 howpublished={online},
 year={2024},
 publisher={Oddział PAN w Krakowie; Uniwersytet Jagielloński – Collegium Medicum},
 abstract={Background: Kidney diseases are a major global health problem affecting millions of people. Despite this, there is as yet no effective drug therapy improving outcome in patients with renal disease. The aim of this study was to examine the nephroprotective effect of α-lipoic acid (ALA) in vitro and to examine the effect of ALA administered in vivo on the production of reactive sulfur species (RSS), including hydrogen sulfide (H2S) and compounds containing sulfane sulfur. Methods: The effect of ALA was studied in vitro by determining the viability of human embryonic kidney cells (HEK293) in normoxic and hypoxic conditions as well as in vivo in two groups of chronic kidney disease (CKD) patients: non-dialyzed (ND) and undergoing continuous ambulatory peritoneal dialysis (PD) after 30 days of ALA supplementation. Results: The results revealed that the viability of HEK293 cells was significantly decreased by hypoxic conditions, while ALA administered during hypoxia increased the viability to the level observed in normoxic conditions. Studies performed in plasma of CKD patients after ALA supplementation suggested that ALA did not affect the parameters of oxidative stress, while significantly increased the level of reactive sulfane sulfur in both ND and PD patients suffering from CKD. The results suggest that ALA can exert nephroprotective effects which are related to sulfane sulfur production.},
 type={Article},
 title={α-Lipoic acid increases the viability of nephrocytes and elevates sulfane sulfur level in plasma of patients with chronic kidney disease},
 URL={http://ochroma.man.poznan.pl/Content/132574/Folia_Medica_2024-1-i-39-52.pdf},
 doi={10.24425/fmc.2024.150140},
 keywords={chronic kidney disease, α-lipoic acid, sulfane sulfur, human embryonic kidney cells (HEK293), oxygen and glucose deprivation and next reoxygenation (OGD/R) procedure},
}